Drug-Eluting Stent Players Face Setback With Lower-Paying DRG Assignment

A provision that could be included in Medicare "giveback" legislation slated to be taken up by Congress this summer would allow drug-eluting stents to be assigned to a higher-paying diagnosis related group (DRG) midway through the fiscal year

More from Archive

More from Medtech Insight